Ms. Hamutal Yitzhak reports

ELSE NUTRITION APPLAUDS U.S. GOVERNMENT'S HISTORIC SHIFT IN INFANT FORMULA RULES, UNLOCKING PATH TO COMMERCIALIZE THE WORLD'S FIRST WHOLE-FOOD, DAIRY-FREE INFANT FORMULA

Else Nutrition Holdings Inc. welcomes a recent trio of significant policy signals from the United States government that could reshape the nation's infant formula landscape.

These developments -- spanning U.S. Food and Drug Administration regulatory reform, congressional oversight and executive action -- reflect growing national momentum to modernize outdated regulations and expand consumer choice in baby formula.

National Academy of Sciences report supports smarter science, aligns with Else's regulatory approach

In a move that could have broad implications for new formula entrants, the FDA commissioned a National Academy of Sciences study to examine global regulatory standards for infant formula -- particularly focusing on the outdated Protein Efficiency Ratio (PER) study, which had long served as a barrier for plant-based options like Else's.

The newly released study recommends replacing the outdated PER test with modern, evidence-based alternatives that better reflect international norms and nutritional science. This marks a turning point for Else, whose regulatory strategy has been built around these same more progressive standards.

"We are encouraged by the academy's findings and look forward to these recommendations informing forthcoming FDA guidance," said Hamutal Yitzhak, chief executive officer and co-founder, Else Nutrition.

congressional pressure grows for modernized plant-based infant formula pathway

In parallel, Else Nutrition welcomes mounting attention to infant formula policy from the United States Congress. Earlier this year, top Republican appropriators -- members of a powerful committee in Congress that maintains the "power of the purse" -- sent a formal congressional oversight letter to the agency, urging the FDA to create a clear, modernized regulatory pathway for plant-based infant formula that matches the international standard. Congress's intent reflects a shared perspective that the National Academy of Science study unveiled.

This rare congressional intervention emphasizes the urgency of reform and calls for U.S. policy to upgrade to international standards that already embrace plant-based options. It also signals the potential for future congressional action to reinforce the need for change and hold the FDA accountable.

"congressional appropriators are sending a strong signal that American parents deserve safe, vetted plant-based alternatives, and that companies like Else deserve a fair, science-aligned path to market, with regulatory guidance to match," added Ms. Yitzhak.

Administration launches Operation Stork Speed to cut red tape

Furthering the support is the administration's new initiative, Operation Stork Speed, aimed at accelerating access to infant formula by streamlining regulatory processes and clearing bureaucratic roadblocks. The program is expected to fast-track FDA reforms while ensuring safety and nutritional integrity.

Else Nutrition looks forward to engaging directly with the administration to help shape a smarter, more inclusive infant formula future.

A new era of opportunity for infant nutrition

Together, these three developments -- scientific, legislative and executive -- signal a generational shift in how the U.S. regulates and supports infant nutrition. For Else Nutrition, they offer renewed confidence that the path forward is finally being cleared. This initiative is a direct complement to the congressional attention and the National Academy of Science study, and Else looks forward to collaborating with the administration.

"These reforms aren't just good for Else -- they're good for every parent seeking cleaner, safer baby formula options beyond dairy," said Ms. Yitzhak. "We continually get requests from so many families in real need of finding an alternative beyond dairy-based baby formula. We're proud to be at the forefront of this movement for change and are ready to serve American families with the trusted nutrition they deserve."

Join the movement -- demand real choice

Else Nutrition is mobilizing parents, pediatric professionals and policymakers to advocate for inclusive, evidence-based nutrition. With public support and FDA co-operation, the company can launch clinical trials and bring its formula to American shelves.

Here is how you can help drive the formula for change:

1. E-mail your member of Congress to urge FDA action on modern regulatory pathways;
2. Sign the petition on the Change website to amplify the public voice.

Disclaimers

This grassroots lobbying effort is a statement of issue advocacy and does not require disclosure under the Lobbying Disclosure Act. This is not an electioneering statement, and this message has not been co-ordinated with any political parties or candidates. This message is paid for by Else Nutrition and is intended for only a "restricted class" of stockholders and administrators of the company. Whereas this is an instance of grassroots lobbying, Else Nutrition's engaged lobbying principals file disclosures required under the Lobbying Disclosure Act for direct lobbying services on behalf of the company.

About Else Nutrition Holdings Inc.

Else Nutrition Holdings is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

We seek Safe Harbor.